Sam-A Pharm Valuation
| 009300 Stock | KRW 17,030 430.00 2.59% |
At this time, the company appears to be overvalued. Sam A Pharm has a current Real Value of W15936.0 per share. The regular price of the company is W17030.0. Our model measures the value of Sam A Pharm from inspecting the company fundamentals such as Operating Margin of 0.07 %, shares outstanding of 6.1 M, and Return On Equity of 6.38 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Sam-A Pharm's price fluctuation is very steady at this time. Calculation of the real value of Sam A Pharm is based on 3 months time horizon. Increasing Sam-A Pharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Sam-A Pharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sam-A Stock. However, Sam-A Pharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17030.0 | Real 15936.0 | Hype 16600.0 | Naive 17118.37 |
The real value of Sam-A Stock, also known as its intrinsic value, is the underlying worth of Sam A Pharm Company, which is reflected in its stock price. It is based on Sam-A Pharm's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sam-A Pharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sam A Pharm Co helps investors to forecast how Sam-A stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sam-A Pharm more accurately as focusing exclusively on Sam-A Pharm's fundamentals will not take into account other important factors: Sam-A Pharm Total Value Analysis
Sam A Pharm Co is presently forecasted to have takeover price of 38.39 B with market capitalization of 108.64 B, debt of 1.51 B, and cash on hands of 7.98 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sam-A Pharm fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
38.39 B | 108.64 B | 1.51 B | 7.98 B |
Sam-A Pharm Investor Information
About 66.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Sam A Pharm had 1119:1097 split on the 29th of December 2008. Sam A Pharm Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Sam-A Pharm Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sam-A Pharm has an asset utilization ratio of 28.9 percent. This suggests that the Company is making W0.29 for each dollar of assets. An increasing asset utilization means that Sam A Pharm Co is more efficient with each dollar of assets it utilizes for everyday operations.Sam-A Pharm Ownership Allocation
The market capitalization of Sam-A Pharm is W108.64 Billion. Sam A Pharm has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.58 % of Sam-A Pharm outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.Sam-A Pharm Profitability Analysis
The company reported the revenue of 54.67 B. Net Income was 3.39 B with profit before overhead, payroll, taxes, and interest of 32.37 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sam-A Pharm's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sam-A Pharm and how it compares across the competition.
About Sam-A Pharm Valuation
The stock valuation mechanism determines Sam-A Pharm's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sam-A Pharm. We calculate exposure to Sam-A Pharm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sam-A Pharm's related companies.Co., Ltd operates as a pharmaceutical company in South Korea. Co., Ltd was founded in 1945 and is based in Seoul, South Korea. Sam A is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Sam-A Pharm's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sam-A Pharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sam-A Pharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sam-A Pharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sam-A Pharm's revenue streams: Identify Sam-A Pharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sam-A Pharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sam-A Pharm's growth potential: Evaluate Sam-A Pharm's management, business model, and growth potential.
- Determine Sam-A Pharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sam-A Pharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Sam-A Stock analysis
When running Sam-A Pharm's price analysis, check to measure Sam-A Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sam-A Pharm is operating at the current time. Most of Sam-A Pharm's value examination focuses on studying past and present price action to predict the probability of Sam-A Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sam-A Pharm's price. Additionally, you may evaluate how the addition of Sam-A Pharm to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |